GW PHARMACEUTICALS PLC Exchange Rate Effect on Cash
GW PHARMACEUTICALS PLC reported Exchange Rate Effect on Cash of -$498.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-03.
Discontinued › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2021-05-03
- GW PHARMACEUTICALS PLC effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2021-03-31 was -$498.00K.
- GW PHARMACEUTICALS PLC effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2020-03-31 was -$3.89M, a 1112.24% decline year-over-year.
- GW PHARMACEUTICALS PLC effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2019-03-31 was $384.00K.
- GW PHARMACEUTICALS PLC effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2018-12-31 was $5.33M.
- GW PHARMACEUTICALS PLC effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for fiscal 2020 was $6.34M, a 18.95% increase from fiscal 2019.
- GW PHARMACEUTICALS PLC effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for fiscal 2019 was $5.33M.
- GW PHARMACEUTICALS PLC effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for fiscal 2018 was -$240.00K, a 102.67% decline from fiscal 2017.
- GW PHARMACEUTICALS PLC effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for fiscal 2017 was $8.99M.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$498.00K 10-Q · filed 2021-05-03 | |||
| 2020-12-31 | $6.34M 10-K · filed 2021-02-26 | |||
| 2020-09-30 | $640.00K 10-Q · filed 2020-11-05 | |||
| 2020-06-30 | -$4.17M 10-Q · filed 2020-08-07 | |||
| 2020-03-31 | -$3.89M 10-Q · filed 2021-05-03 | |||
| 2019-12-31 | $5.33M 10-K · filed 2021-02-26 | |||
| 2019-09-30 | -$4.47M 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | -$893.00K 10-Q · filed 2020-08-07 | |||
| 2019-03-31 | $384.00K 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | $5.33M 10-K · filed 2021-02-26 | |||
| 2018-09-30 | $131.00K 10-Q · filed 2019-11-06 | -$240.00K 10-K · filed 2021-02-26 | ||
| 2017-12-31 | -$371.00K 10-K · filed 2021-02-26 | |||
| 2017-09-30 | $8.99M 10-K · filed 2020-02-27 |